Summary: BBC Future profiles MAPS Founder Rick Doblin, Ph.D., in an extensive article exploring the international impact of psychedelics on science, drug policy, culture, and medicine. By highlighting the rapid increase in psychedelic research over the past ten years, Ed Prideaux of BBC explains how clinical trial results, favorable media coverage, and the potential development of new mental health treatments are steadily moving the public perception of psychedelics toward mainstream acceptance. “Now the efforts of Doblin and others are finally paying off,” writes Prideaux. “Promising clinical trials suggest that psychedelics may prove game-changing treatments for depression, PTSD and addiction.”
Originally appearing here.